Medtech

Ambu retires main argument for single-use endoscopes

The argument that reusable equipment increases the risk of spreading infections does not seem to have gained ground in hospitals – so the medtech company is coming up with different reasons.
Under a new strategy, Meelby Jensen will attempt to win over the endoscope market with a different selling point | Photo: Ambu/pr
Under a new strategy, Meelby Jensen will attempt to win over the endoscope market with a different selling point | Photo: Ambu/pr
by ulrich quistgaard, translated by daniel pedersen

Chief Executive Officer at Ambu Britt Meelby Jensen is ending a persuasion tactic for why the market should make a switch from reusable endoscope to single-use products.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Related articles

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading

    Jobs